Gajanan Kashinathrao Arbade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gajanan Kashinathrao Arbade has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- T. Umasankar Patro
School of Materials and Chemical Sciences, Defence Institute of Advanced Technology, Pune, 411025, India
4 shared publications Vidisha Tripathi
National Centre for Cell Science, Pune- 411007, Maharashtra, India
3 shared publicationsShivaji Kashte
Department of Stem Cell and Regenerative Medicine, D. Y. Patil Education Society (Deemed to be University)
2 shared publications- Aishwarya Vijayan Menon
Purdue University
1 shared publication Anil Babu Katiki
Manipal Institute of Regenerative Medicine, Bengaluru, Manipal Academy of Higher Education
1 shared publicationJuhi Srivastava
National Centre for Cell Science, Pune, Maharashtra, India
1 shared publication
Latest Publications
- 14 August 2025
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 37 (7) , 1295-1326
Prospects of injectable hydrogels for bone tissue engineering applications
In recent years, biomaterial-based tissue engineering approaches have efficiently treated bone defects caused by extensive trauma, fractures, and diseases. The repair and restoration of normal function of such defective bone tissues is a prominent global clinical demand. Among the biomaterial scaffolds used in TE, injectable hydrogels have gained tremendous potential in bone tissue engineering (BTE) due to their favorable properties like high water content, biomimicking with natural extracellular matrix, controlled mechanical properties, minimal invasiveness, and ability to match irregular defects. The present review focuses on preparing injectable hydrogels, their types, properties, and applications, with special emphasis on BTE. Further, the synergistic effect of hydrogels with other biomaterials and cell-encapsulated hydrogels for BTE has been discussed. A final deliberation has been made to emphasize the prospects of injectable hydrogels and their implementation for critical defects.
- 14 August 2025
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 37 (7) , 1295-1326
Prospects of injectable hydrogels for bone tissue engineering applications
In recent years, biomaterial-based tissue engineering approaches have efficiently treated bone defects caused by extensive trauma, fractures, and diseases. The repair and restoration of normal function of such defective bone tissues is a prominent global clinical demand. Among the biomaterial scaffolds used in TE, injectable hydrogels have gained tremendous potential in bone tissue engineering (BTE) due to their favorable properties like high water content, biomimicking with natural extracellular matrix, controlled mechanical properties, minimal invasiveness, and ability to match irregular defects. The present review focuses on preparing injectable hydrogels, their types, properties, and applications, with special emphasis on BTE. Further, the synergistic effect of hydrogels with other biomaterials and cell-encapsulated hydrogels for BTE has been discussed. A final deliberation has been made to emphasize the prospects of injectable hydrogels and their implementation for critical defects.
- 8 July 2024
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 74 (9) , 812-828
Zein-based polymeric biomaterials: an overview for applications in soft tissue engineering
- 8 July 2024
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 74 (9) , 812-828
Zein-based polymeric biomaterials: an overview for applications in soft tissue engineering
- 15 September 2020
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 71 (3) , 208-219
Effect of poly(ethylene glycol) on drug delivery, antibacterial, biocompatible, physico-chemical and thermo-mechanical properties of PCL-chloramphenicol electrospun nanofiber scaffolds
The present study investigates the effect of poly(ethylene glycol) (PEG) addition on physico-chemical, thermo-mechanical, drug release, antibacterial and biocompatible properties of poly(ε-caprolactone) (PCL)-chloramphenicol (CAP) electrospun nanofiber scaffolds. Incorporation of PEG imparted enhanced hydrophilicity, crystallinity, glass transition temperature and cell growth ability and reduced cytotoxicity in PCL. In vitro drug release studies reveal that PEG addition in PCL-CAP facilitated well-defined release kinetics and the release profiles follow the Ritger–Peppas and Korsmeyer–Peppas model. The drug-loaded scaffolds showed antibacterial properties against both Gram-positive and Gram-negative bacterial strains. Further, addition of PEG significantly improved the biocompatibility of the PCL-CAP scaffolds.
- 15 September 2020
- Published by Taylor & Francis in International Journal of Polymeric Materials and Polymeric Biomaterials
- Vol. 71 (3) , 208-219
Effect of poly(ethylene glycol) on drug delivery, antibacterial, biocompatible, physico-chemical and thermo-mechanical properties of PCL-chloramphenicol electrospun nanofiber scaffolds
The present study investigates the effect of poly(ethylene glycol) (PEG) addition on physico-chemical, thermo-mechanical, drug release, antibacterial and biocompatible properties of poly(ε-caprolactone) (PCL)-chloramphenicol (CAP) electrospun nanofiber scaffolds. Incorporation of PEG imparted enhanced hydrophilicity, crystallinity, glass transition temperature and cell growth ability and reduced cytotoxicity in PCL. In vitro drug release studies reveal that PEG addition in PCL-CAP facilitated well-defined release kinetics and the release profiles follow the Ritger–Peppas and Korsmeyer–Peppas model. The drug-loaded scaffolds showed antibacterial properties against both Gram-positive and Gram-negative bacterial strains. Further, addition of PEG significantly improved the biocompatibility of the PCL-CAP scaffolds.
- 7 June 2020
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 31 (13) , 1648-1670
Enhancement of hydrophilicity, biocompatibility and biodegradability of poly(ε-caprolactone) electrospun nanofiber scaffolds using poly(ethylene glycol) and poly(L-lactide-co-ε-caprolactone-co-glycolide) as additives for soft tissue engineering
In this study, poly(ε-caprolactone) (PCL) has been blended with a more hydrophilic poly(ethylene glycol) (PEG) and with a biocompatible block-co-polymer: poly(L-lactide-co-ε-caprolactone-co-glycolide) (PLCG) in order to improve hydrophilicity, biocompatibility and biodegradability of PCL. PCL and the blend solutions were subjected to electrospinning to produce nanofiber scaffolds by the addition of only 1wt% of PEG and PLCG either singly or in combination in PCL to retain the mechanical properties of the scaffolds. PCL-PEG-PLCG ternary and two binary (PCL-PEG and PCL-PLCG) blend nanofiber scaffolds have been prepared for comparison. The resulting nanofibers showed a smooth and flaw-free surface and the diameter of the nanofibers displayed a normal distribution. The PCL-PEG nanofiber scaffold showed improved hydrophilicity [water contact angle (WCA) ∼84°] over pristine PCL (WCA ∼127°); while PCL-PLCG and PCL-PEG-PLCG scaffolds exhibited absolute wetting by water, likely due to high porosity. In vitro biocompatibility studies using gingival mesenchymal stem cells (gMSCs) suggested that, both the PCL and the blend scaffolds were biocompatible supporting cell-viability and growth of gMSCs following their seeding on these scaffolds. Biodegradation studies in phosphate buffer solution showed that the addition of PEG and PLCG in PCL increased the weight loss of scaffolds with time, indicating higher extent of biodegradation in the blend scaffolds and the weight loss followed the power law curve with time.
- 7 June 2020
- Published by Taylor & Francis in Journal of Biomaterials Science, Polymer Edition
- Vol. 31 (13) , 1648-1670
Enhancement of hydrophilicity, biocompatibility and biodegradability of poly(ε-caprolactone) electrospun nanofiber scaffolds using poly(ethylene glycol) and poly(L-lactide-co-ε-caprolactone-co-glycolide) as additives for soft tissue engineering
In this study, poly(ε-caprolactone) (PCL) has been blended with a more hydrophilic poly(ethylene glycol) (PEG) and with a biocompatible block-co-polymer: poly(L-lactide-co-ε-caprolactone-co-glycolide) (PLCG) in order to improve hydrophilicity, biocompatibility and biodegradability of PCL. PCL and the blend solutions were subjected to electrospinning to produce nanofiber scaffolds by the addition of only 1wt% of PEG and PLCG either singly or in combination in PCL to retain the mechanical properties of the scaffolds. PCL-PEG-PLCG ternary and two binary (PCL-PEG and PCL-PLCG) blend nanofiber scaffolds have been prepared for comparison. The resulting nanofibers showed a smooth and flaw-free surface and the diameter of the nanofibers displayed a normal distribution. The PCL-PEG nanofiber scaffold showed improved hydrophilicity [water contact angle (WCA) ∼84°] over pristine PCL (WCA ∼127°); while PCL-PLCG and PCL-PEG-PLCG scaffolds exhibited absolute wetting by water, likely due to high porosity. In vitro biocompatibility studies using gingival mesenchymal stem cells (gMSCs) suggested that, both the PCL and the blend scaffolds were biocompatible supporting cell-viability and growth of gMSCs following their seeding on these scaffolds. Biodegradation studies in phosphate buffer solution showed that the addition of PEG and PLCG in PCL increased the weight loss of scaffolds with time, indicating higher extent of biodegradation in the blend scaffolds and the weight loss followed the power law curve with time.
- 6 November 2019
- Published by Springer Nature
- p. 43-66
Biocompatible Polymer Based Nanofibers for Tissue Engineering
- 6 November 2019
- Published by Springer Nature
- p. 43-66
Biocompatible Polymer Based Nanofibers for Tissue Engineering
- 10 April 2019
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 43 (19) , 7427-7440
Emblica officinalis -loaded poly(ε-caprolactone) electrospun nanofiber scaffold as potential antibacterial and anticancer deployable patch
Biological functions of nanofiber scaffolds can be engineered via the incorporation of plant extracts. In the present study, Emblica officinalis (EO) (Indian Gooseberry known as amla)-loaded poly(ε-caprolactone) (PCL) nanofibers were prepared via the electrospinning technique. The aim was to prepare nanofiber scaffolds with antibacterial and anti-cancerous properties. The scaffolds were characterized via SEM, XRD, small-angle X-ray scattering, FTIR spectroscopy, streaming potential, DSC, water contact angle and tensile measurements. Upon the incorporation of EO, the nanofiber surface became rougher and exhibited a ‘braid-like’ morphology. This is in contrast to the pristine PCL nanofibers, which exhibited a smooth fiber surface. The average fiber diameter increased, and the water contact angle of the nanofiber scaffolds decreased with an increase in the EO content in PCL. The crystalline structure of PCL was not affected; however, its crystallization temperature increased significantly and its melting temperature increased marginally with the addition of EO. The PCL scaffold showed a negatively charged surface and its ξ-potential increased with an increase in EO content due to the presence of various functional groups. The antibacterial studies revealed that the PCL–EO nanofiber scaffolds exhibited efficient antibacterial properties against both Gram-positive and Gram-negative bacterial strains and the zone of inhibition increased with EO content. Furthermore, cellular behavior of MCF-7 cells was studied using the MTT assay, fluorescent staining and SEM, which indicated that cell proliferation was significantly inhibited by the incorporation of EO in the scaffolds.
- 10 April 2019
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 43 (19) , 7427-7440
Emblica officinalis -loaded poly(ε-caprolactone) electrospun nanofiber scaffold as potential antibacterial and anticancer deployable patch
Biological functions of nanofiber scaffolds can be engineered via the incorporation of plant extracts. In the present study, Emblica officinalis (EO) (Indian Gooseberry known as amla)-loaded poly(ε-caprolactone) (PCL) nanofibers were prepared via the electrospinning technique. The aim was to prepare nanofiber scaffolds with antibacterial and anti-cancerous properties. The scaffolds were characterized via SEM, XRD, small-angle X-ray scattering, FTIR spectroscopy, streaming potential, DSC, water contact angle and tensile measurements. Upon the incorporation of EO, the nanofiber surface became rougher and exhibited a ‘braid-like’ morphology. This is in contrast to the pristine PCL nanofibers, which exhibited a smooth fiber surface. The average fiber diameter increased, and the water contact angle of the nanofiber scaffolds decreased with an increase in the EO content in PCL. The crystalline structure of PCL was not affected; however, its crystallization temperature increased significantly and its melting temperature increased marginally with the addition of EO. The PCL scaffold showed a negatively charged surface and its ξ-potential increased with an increase in EO content due to the presence of various functional groups. The antibacterial studies revealed that the PCL–EO nanofiber scaffolds exhibited efficient antibacterial properties against both Gram-positive and Gram-negative bacterial strains and the zone of inhibition increased with EO content. Furthermore, cellular behavior of MCF-7 cells was studied using the MTT assay, fluorescent staining and SEM, which indicated that cell proliferation was significantly inhibited by the incorporation of EO in the scaffolds.
- 1 April 2019
- Published by Trans Tech Publications, Ltd. in Journal of Biomimetics, Biomaterials and Biomedical Engineering
- Vol. 41, 49-68
Herbally Painted Biofunctional Scaffolds with Improved Osteoinductivity for Bone Tissue Engineering
In the bone tissue engineering composite scaffolds with osteogenic potential are emerging as the new tool. Here, we investigated the graphene (GP), graphene oxide (GO) and Cissus quadrangularis (CQ) callus extract for their spontaneous osteoinductive potential. Electrospun poly ε-caprolactone (PCL) sheets were painted with varying combination GP, GO and CQ solutions as ink. The prepared PCL-GO, PCL-GO-CQ, PCL-GP and PCL-GP-CQ scaffolds were characterized for their physical, mechanical and biological properties. Addition of GO, GP, GO-CQ and GP-CQ to PCL enhanced roughness, wettability, Yield strength and tensile strength, biocompatibility .significantly. Presence of GO and CQ in PCL-GO-CQ scaffolds, while GP and CQ in PCL-GP-CQ scaffolds showed synergistic effect on the biocompatibility, Cell attachment,cell proliferation of human umbilical Wharton’s jelly derived mesenchymal stem cells (hUCMSCs) and their differentiation into osteoblasts by 21st day in culture without osteogenic differentiation media or any growth factors. Same is confirmed by the Alizarin red S staining and Von kossa staining. The combination of PCL-GO-CQ scaffold prepared by novel paint method was found to be the most potential in bone tissue engineering.
- 1 April 2019
- Published by Trans Tech Publications, Ltd. in Journal of Biomimetics, Biomaterials and Biomedical Engineering
- Vol. 41, 49-68
Herbally Painted Biofunctional Scaffolds with Improved Osteoinductivity for Bone Tissue Engineering
In the bone tissue engineering composite scaffolds with osteogenic potential are emerging as the new tool. Here, we investigated the graphene (GP), graphene oxide (GO) and Cissus quadrangularis (CQ) callus extract for their spontaneous osteoinductive potential. Electrospun poly ε-caprolactone (PCL) sheets were painted with varying combination GP, GO and CQ solutions as ink. The prepared PCL-GO, PCL-GO-CQ, PCL-GP and PCL-GP-CQ scaffolds were characterized for their physical, mechanical and biological properties. Addition of GO, GP, GO-CQ and GP-CQ to PCL enhanced roughness, wettability, Yield strength and tensile strength, biocompatibility .significantly. Presence of GO and CQ in PCL-GO-CQ scaffolds, while GP and CQ in PCL-GP-CQ scaffolds showed synergistic effect on the biocompatibility, Cell attachment,cell proliferation of human umbilical Wharton’s jelly derived mesenchymal stem cells (hUCMSCs) and their differentiation into osteoblasts by 21st day in culture without osteogenic differentiation media or any growth factors. Same is confirmed by the Alizarin red S staining and Von kossa staining. The combination of PCL-GO-CQ scaffold prepared by novel paint method was found to be the most potential in bone tissue engineering.
- 17 May 2018
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 4 (4) , 045011
Antibacterial, sustained drug release and biocompatibility studies of electrospun poly( ε -caprolactone)/chloramphenicol blend nanofiber scaffolds
Controlled drug release and antibacterial properties of electrospun nanofiber depend on slow release of drug molecules to the targeted area by diffusion and antibacterial properties of drug embedded in the nanofiber. In the present study, chloramphenicol (CAP), an antibacterial drug has been incorporated in poly( ε -caprolactone) (PCL) nanofibers in the weight content of 5–20 wt% by electrospinning. It was found that the fiber diameter and hydrophilic nature of nanofibers increased with increase in CAP content. The latter phenomenon is expected to facilitate biocompatibility of scaffolds. The scaffolds showed excellent antibacterial properties against gram positive ( Staphylococcus aureus and Bacillus subtilis ) as well as gram negative ( Escherichia coli, Pseudomonas aeruginosa and Flavobacterium devorans ) bacterial strains commonly associated with wound and burn infections. In-vitro drug release studies were carried out in phosphate buffer saline at pH ∼ 7.4. The release was found to be saturated in about 20 days and the maximum release was ∼80%. Nanofiber scaffolds with 5 wt% CAP content showed the highest release rate among the scaffolds studied, which could be attributed to the smaller fiber diameter of this scaffold leading to higher surface area. The composite nanofiber scaffolds were further studied for cell adhesion, proliferation and toxicity using human colon colorectal epithelial cells (HCT 116 WT) in vitro . The cells are found to show excellent adhesion and proliferation on both PCL and CAP embedded scaffolds in large numbers. However, CAP loaded scaffolds showed better cell proliferation than that of neat PCL counterpart.
- 17 May 2018
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 4 (4) , 045011
Antibacterial, sustained drug release and biocompatibility studies of electrospun poly( ε -caprolactone)/chloramphenicol blend nanofiber scaffolds
Controlled drug release and antibacterial properties of electrospun nanofiber depend on slow release of drug molecules to the targeted area by diffusion and antibacterial properties of drug embedded in the nanofiber. In the present study, chloramphenicol (CAP), an antibacterial drug has been incorporated in poly( ε -caprolactone) (PCL) nanofibers in the weight content of 5–20 wt% by electrospinning. It was found that the fiber diameter and hydrophilic nature of nanofibers increased with increase in CAP content. The latter phenomenon is expected to facilitate biocompatibility of scaffolds. The scaffolds showed excellent antibacterial properties against gram positive ( Staphylococcus aureus and Bacillus subtilis ) as well as gram negative ( Escherichia coli, Pseudomonas aeruginosa and Flavobacterium devorans ) bacterial strains commonly associated with wound and burn infections. In-vitro drug release studies were carried out in phosphate buffer saline at pH ∼ 7.4. The release was found to be saturated in about 20 days and the maximum release was ∼80%. Nanofiber scaffolds with 5 wt% CAP content showed the highest release rate among the scaffolds studied, which could be attributed to the smaller fiber diameter of this scaffold leading to higher surface area. The composite nanofiber scaffolds were further studied for cell adhesion, proliferation and toxicity using human colon colorectal epithelial cells (HCT 116 WT) in vitro . The cells are found to show excellent adhesion and proliferation on both PCL and CAP embedded scaffolds in large numbers. However, CAP loaded scaffolds showed better cell proliferation than that of neat PCL counterpart.
- Open Access
- 7 December 2016
- Published by MedCrave Group Kft. in Journal of Applied Biotechnology and Bioengineering
- Vol. 1 (2) , 1-5
Extra Cytoplasmic Sigma Factors in Staphylococcus aureus; their Role and Significance in the Survival of Cocci
- 7 December 2016
- Published by MedCrave Group Kft. in Journal of Applied Biotechnology and Bioengineering
- Vol. 1 (2) , 1-5
Open AccessExtra Cytoplasmic Sigma Factors in Staphylococcus aureus; their Role and Significance in the Survival of Cocci
- Open Access
- 22 May 2015
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 71 (6) , 763-769
Cloning, expression, purification, crystallization and preliminary X-ray diffraction studies of NAD synthetase from methicillin-resistantStaphylococcus aureus
Staphylococcus aureusis an important human and animal pathogen that causes a wide range of infections. The prevalence of multidrug-resistantS. aureusstrains in both hospital and community settings makes it imperative to characterize new drug targets to combatS. aureusinfections. In this context, enzymes involved in NAD metabolism and synthesis are significant drug targets as NAD is a central player in several cellular processes. NAD synthetase catalyzes the last step in the biosynthesis of nicotinamide adenine dinucleotide, making it a crucial intermediate enzyme linked to the biosynthesis of several amino acids, purine and pyrimidine nucleotides, coenzymes and antibiotics.
- 22 May 2015
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology Communications
- Vol. 71 (6) , 763-769
Open AccessCloning, expression, purification, crystallization and preliminary X-ray diffraction studies of NAD synthetase from methicillin-resistantStaphylococcus aureus
Staphylococcus aureusis an important human and animal pathogen that causes a wide range of infections. The prevalence of multidrug-resistantS. aureusstrains in both hospital and community settings makes it imperative to characterize new drug targets to combatS. aureusinfections. In this context, enzymes involved in NAD metabolism and synthesis are significant drug targets as NAD is a central player in several cellular processes. NAD synthetase catalyzes the last step in the biosynthesis of nicotinamide adenine dinucleotide, making it a crucial intermediate enzyme linked to the biosynthesis of several amino acids, purine and pyrimidine nucleotides, coenzymes and antibiotics.